Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinical deep-dive into flibanserin (Addyi) adverse events stratified by patient phenotype, including CNS sensitivity, alcohol use, CYP2C19 metabolism, and comorbidity burden, with trial data, FAERS analysis, and dosing guidance.
Read clinical reviewA clinical deep-dive into flibanserin (Addyi) delayed-onset side effects, including dizziness, hypotension, CNS depression, and rare FAERS-reported reactions, with prescribing guidance and monitoring tips.
Read clinical reviewA physician-reviewed breakdown of flibanserin (Addyi) adverse event rates from phase III trials, FDA review documents, FAERS data, and post-market literature, with exact percentages, named studies, and clinical guidance.
Read clinical reviewA physician-reviewed look at Addyi (flibanserin) side effects, including rare and potentially lasting adverse events, drawn from clinical trials, FDA labeling, and FAERS post-market data.
Read clinical reviewA clinical deep-dive into the rare but serious adverse events associated with flibanserin (Addyi), including syncope, CNS depression, and hypotension, with data from FDA labeling, FAERS, and post-market surveillance.
Read clinical reviewA clinician-reviewed guide to flibanserin (Addyi) withdrawal and discontinuation syndrome, covering mechanism, documented adverse events, FAERS data, clinical trial findings, and how to stop safely.
Read clinical review